Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.
Chapman
B A
BA
Burt
M J
MJ
Frampton
C M
CM
Chapman
T M
TM
Whitehead
M R
MR
Upton
J D
JD
George
P M
PM
D000998:Antiviral Agents / Q000378:metabolism / Q000627:therapeutic use*; D006432:Hemochromatosis / Q000235:genetics* / Q000378:metabolism; D006526:Hepatitis C / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000378:metabolism / Q000627:therapeutic use*; D007501:Iron / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007501:Iron